Search

everythinglearnresearchcommunity

for

Search:↓

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Adiantum capillus extract reduces pain and swelling in animals.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.